| Quality Assurance Review Center |
Article Index for Quality Assurance |
Website Links For Quality Assurance |
Information AboutQuality Assurance Review Center |
| CATEGORIES ABOUT QUALITY ASSURANCE REVIEW CENTER | |
| cancer organizations | |
| medical research institutes | |
| non-profit organizations | |
| national institutes of health | |
| radiation oncology | |
|
DEPARTMENTS AND DIVISIONS QARC is divided into three separate sectors, namely that of Physics / Dosimetry , Data Management , and Operations . Physics/Dosimetry Department The Physics/Dosimetry department is primarily concerned with evaluating the radiation Dose calculations submitted with each patient on any given Protocol . In addition, the department works closely with various institutions, which include the public Oncology groups and the private pharmaceutical industry, to develop and implement new benchmarks for specific areas of radiation therapy. In keeping with its responsibility as a quality assurance agent, the department participates in initial, interventional, and final reviews so as to insure the highest degree of integrity with regard to protocol guidelines. Data Management Division The Data Management division receives and processes all forms of data relating to any given patient on any given protocol. Typical forms of data include diagnostic imaging, physics benchmarks, and Radiology reports. The diagnostic imaging segment of data management usually involves Computed Tomography (CT), Positron Emission Tomography (PET), and Magnetic Resonance Imaging (MRI) scans. Occasionally, QARC will obtain Gallium and Bone scans insofar as a protocal mandates them. With the shift toward Nuclear Medicine in radiology, QARC seeks to build and maintain a vast database with its data management division. Operations Department The Operations department is predominantly focused on constructing and sustaining working relationships between QARC and the various NCI supported oncology groups as well as the pharmaceutical industry. It also collaborates with its UMASS Medical School affiliate in matters pertaining to accounting and employment. Past and present pharmaceutical contracts for clinical trials at QARC include Sanofi-Aventis , Amgen , and GlaxoSmithKline . The NCI oncology groups including ACOSOG , COG , ECOG , SWOG , and CALGB all mandate that the radiotherapy materials for their protocols be sent to QARC for review. REFERENCES EXTERNAL LINKS |
|
|